NY-EMENDO-BIO
Emendo Biotherapeutics presented the results of its next generation CRISPR-based gene editing approaches for several indications in an oral presentation and three posters at the 25th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) held May 16-19, 2022, in Washington, D.C.
Emendo presented pre-clinical data for the treatment of ELANE -related Severe Congenital Neutropenia using an allele-specific editing approach, demonstrating the power of Emendo’s dual technology platforms that enable the development of a highly specific editing composition that demonstrates no off-targets and complete allele specificity. Significantly, the lack of off-target achieved by Emendo’s engineered and optimized OMNI nuclease also eliminated any translocations. Edited patient derived CD34+ cells differentiated normally into neutrophils both in-vitro and in-vivo , showing full engraftment and reconstitution of all blood lineages, as required for the desired therapeutic effect.
“ELANE -based Severe Congenital Neutropenia, Emendo’s lead indication, is a devastating disease affecting pediatric patients that until now has been incurable,” said David Baram, Ph.D., President & CEO of Emendo Biotherapeutics. “We are excited by the potentially curative treatment developed by our team and were pleased to present our pre-clinical results for this program and other diverse applications of our dual gene editing technology platforms at this year’s ASGCT meeting. And of course, we look forward to the discussion generated by our discoveries around Type II CRISPR nuclease classifications that promise to be ground-breaking in the field.”
Senior members of the Emendo Biotherapeutics R&D team including Chief Technology Officer Lior Izhar, Ph.D. and Executive Vice-President Research & Development Rafi Emmanuel, Ph.D. presented Emendo’s research on-site at the conference.
Session Presentation
Title: A Novel Engineered CRISPR-Associated Nuclease Accurately Removes ELANE Mutated Allele and Shifts HSC Differentiation Towards Neutrophils in Severe Congenital Neutropenia
Session Title: Gene Therapy for Immunologic Diseases
Session Date/Time: Tuesday May 17, 2022 3:45 PM - 5:30 PM
Presentation Time: 3:45pm - 4:00pm
Room: Room 202
Final abstract number: 482
Poster Presentations
Title: A Unique CRISPR-Based Nuclease with a Non-NGG PAM Efficiently Targets Multiple Exclusive Genomic Sites for Immuno-Oncology Based Therapy
Session Title: Cancer - Targeted Gene and Cell Therapy I
Session Date/Time: Monday May 16, 2022 5:30 PM - 6:30 PM
Poster Board Number: M-215
Room: Hall D
Final abstract number: 334
Title: CRISPR-Based Gene Editing Enhances LDLR Expression and Boosts LDL-C Uptake in Familial Hypercholesterolemia
Session Title: Metabolic, Storage, Endocrine, Liver and Gastrointestinal Diseases II
Session Date/Time: Wednesday May 18, 2022 5:30 PM - 6:30 PM
Poster Board Number: W-125
Room: Hall D
Final abstract number: 999
Title: Challenges and Inconsistencies in Type II CRISPR-Associated Nuclease Subtype Classification
Session Title: Gene Targeting and Gene Correction II
Session Date/Time: Tuesday May 17, 2022 5:30 PM - 6:30 PM
Poster Board Number: Tu-61
Room: Hall D
Final abstract number: 556
About Emendo Biotherapeutics
Emendo Biotherapeutics, a subsidiary of AnGes, Inc., is a next generation CRISPR gene editing company leveraging dual proprietary technology platforms to enable high precision gene editing throughout the genome. Emendo’s novel nuclease discovery platform broadens the targetable range of the genome while its target-specific optimization platform enables highly precise editing, including allele specific editing, while maintaining high efficiencies. The capabilities of the OMNI technology platforms, along with deep expertise in genomic medicine, protein engineering and therapeutic development, provide Emendo with a unique advantage when addressing indications within hematology, oncology, ophthalmology and other disease areas. For more information please visit www.emendobio.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006030/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BAT Announces 70% of Policy Experts Continue to Misidentify Nicotine as Primary Cause of Smoking-related Disease5.10.2025 13:00:00 CEST | Press release
Multi-market survey of 450 policy experts1 shows that they continue to see nicotine as a primary cause of smoking-related disease, despite the growing weight of evidence to the contrary Conducted in 2024 and 2025 across 15 different markets, this research also highlights regional disparities in nicotine risk perception due to regulatory barriers and lack of medical guidanceData released ahead of the start of this year’s Global Tobacco and Nicotine Forum (GTNF) in Brussels, with BAT’s Chief Corporate Officer Kingsley Wheaton due to speak BAT announces that a new multi-market survey of policy experts across 15 different territories reveals that erroneous perceptions of nicotine health risks continue to persist, despite both the growing scientific consensus that nicotine is not a primary cause of smoking-related disease and the increased availability of smokeless alternatives to conventional cigarettes. The survey, commissioned by British American Tobacco (BAT) and released ahead of the s
Sharjah Ruler Opens Centre for Arabic Studies in Portugal4.10.2025 21:42:00 CEST | Press release
His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, opened the Centre for Arabic Studies at the University of Coimbra in Portugal, in the presence of Her Highness Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority (SBA). His Highness also launched the Joanina Digital Library, presented the library with the rare Barbosa manuscript dated 1565, and signed his book “A Momentous Journey”, published in Arabic, English and Portuguese. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251004071025/en/ Sharjah Ruler opens Centre for Arabic Studies in Portugal (Photo: AETOSWire) His Highness unveiled a commemorative plaque marking the opening of the centre, before reviewing its services, resources and programmes that support Arabic teaching. He then proceeded to the historic Joanina Library at the University of Coimbra, where he launched the Joanina Digital Libra
Andersen Consulting styrker sin platform med NewVision Solutions4.10.2025 02:11:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter udvidelsen af sine kompetencer via en samarbejdsaftale med NewVision Solutions – et konsulentfirma med speciale i markedsadgangsstrategi, markedsanalyse samt infrastruktur- og ingeniørløsninger. NewVision Solutions, der blev grundlagt i 2008 og har base i Bangladesh, understøtter og faciliterer udenlandske investeringer og hjælper organisationer med at navigere i komplekse markeder gennem finansiel due diligence, regnskabsrådgivning, strukturering af joint ventures og infrastrukturkonsulentbistand. Firmaets skræddersyede tilgang hjælper en bred kundebase, herunder offentlige institutioner, private virksomheder og udviklingsorganisationer. "Hos NewVision er vores mål at forenkle kompleksitet for vores kunder – hvad enten det handler om at vejlede angående markedsadgang, facilitere investeringer eller navigere i regulatoriske landskaber," siger Tareq Rafi Bhuiyan Jun, der er administrerende direktør for NewVision Solutions. "Vi kombinerer global erfaring me
Independent Research Firm Names Mindbreeze a Leader in the Cognitive Search Platforms Evaluation3.10.2025 16:57:00 CEST | Press release
Mindbreeze, a leading global provider of AI-based knowledge management solutions, has been recognized as a Leader in The Forrester Wave™: Cognitive Search Platforms, Q4 2025. Forrester evaluated fourteen cognitive search providers based on their current offering, strategy, and customer feedback. Mindbreeze received recognition for its robust and secure platform, positive customer experiences, and vision for enabling enterprises to transform knowledge into an asset they can act on in real time. Access a complimentary copy of the report from the Mindbreeze website. In its evaluation, Forrester notes that “Mindbreeze is a great fit for enterprises that want a cognitive search platform that is both highly secure and highly flexible.” The report also notes that “Mindbreeze’s superior capabilities include a robust pipeline for ingesting, understanding, and contextually indexing data.” Customers interviewed by Forrester further “report very positive experiences working with the Mindbreeze tea
World Green Economy Summit Hosts a High-Level Ministerial Roundtable3.10.2025 15:22:00 CEST | Press release
HE Saeed Mohammed Al Tayer, Chairman of the World Green Economy Organization (WGEO), delivered the opening address at the high-level roundtable hosted by WGEO during the 11th World Green Economy Summit in Dubai. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251003594739/en/ World Green Economy Summit hosts a high-level ministerial roundtable (Photo: AETOSWire) The session, held under the theme ‘Delivering Climate Ambition by 2030 and Beyond–United Action for Green Transition’, aimed to advance climate ambitions and promote dialogue on aligning policies, finance and innovation with sustainable development. It was attended by HE Dr Amna bint Abdullah Al Dahak, UAE Minister of Climate Change and Environment; HE Dr. Ayman Suleiman, Minister of Environment, Jordan; HE Dorin Junghietu, Minister of Energy, Moldova; HE Dr. Muaviyath Mohamed, Minister of State for Tourism and Environment, Maldives; HE Abubakar Ben Mahmoud Minister o
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom